Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,143,701
-
Share change
-
+697,822
-
Total reported value
-
$521,923,638
-
Put/Call ratio
-
2139%
-
Price per share
-
$22.55
-
Number of holders
-
85
-
Value change
-
+$15,274,819
-
Number of buys
-
54
-
Number of sells
-
27
Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q2 2019
As of 30 Jun 2019,
DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,143,701 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., ORBIMED ADVISORS LLC, Redmile Group, LLC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, SV Health Investors, LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ALKEON CAPITAL MANAGEMENT LLC, and STATE STREET CORP.
This page lists
85
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.